The long-term efficacy of cilostazol in addition to dual antiplatelet therapy after sirolimus-eluting stent implantation for Japanese patients: an analysis of the 3-year follow-up outcomes from the j-Cypher registry.

Abstract

Several clinical studies have reported the use of cilostazol in addition to aspirin and thienopyridine (triple antiplatelet therapy, TAPT) after percutaneous coronary intervention (PCI) decreases clinical events. However, the efficacy and safety of TAPT have not been fully evaluated in Japan. The prospectively collected data from 12824 Japanese patients… (More)

Topics

Cite this paper

@article{Nakao2012TheLE, title={The long-term efficacy of cilostazol in addition to dual antiplatelet therapy after sirolimus-eluting stent implantation for Japanese patients: an analysis of the 3-year follow-up outcomes from the j-Cypher registry.}, author={Tetsushi Nakao and Takeshi Kimura and Takeshi Morimoto and Yutaka Furukawa and Yoshihisa Nakagawa and Kazushige Kadota and Masakiyo Nobuyoshi and Toru Kita and Kazuaki Mitsudo}, journal={Cardiovascular intervention and therapeutics}, year={2012}, volume={27 3}, pages={161-7} }